Dr. Bethan Lloyd-Lewis, a Vice-Chancellor’s Research Fellow at the School of Cellular and Molecular Medicine (CMM), has been awarded a £3.1 million fellowship from the Wellcome Trust to lead research into the regulatory mechanisms influencing stem cell fate decisions during organ development and cancer.
Early warning signs of diseases caused by dysfunctional levels of stress hormones could be spotted more easily thanks to a new wearable device developed by endocrine researchers. This is the first time it has been possible to measure changes to people’s stress hormones as they go about normal daily activities, across both day and night. The new collaborative research led by the University of Bristol, University of Birmingham and University of Bergen has the potential to revolutionise how diseases of the stress hormone system are diagnosed and treated.
The adaptations people of working age with advanced cancer make so they can continue participating in everyday life are explored in a paper published in Palliative Medicine. The paper, ‘The intentional pursuit of everyday life while dying’, is from NIHR ARC West’s Dr Julie Brose’s PhD at the Research Centre for Palliative Care, Death and Dying.
Advanced tools and more experimental studies are needed to urgently understand the impact of extreme heat events on urban health and wellbeing in the UK.
The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer and for which licensed drugs could be clinically trialled to find out if they could treat the disease. The research led by the University of Bristol and published in Neuro-Oncology Advances also found genetic differences between smokers and non-smokers.
The Medical Research Council Integrative Epidemiology Unit (MRC IEU) at the University of Bristol has been awarded funding to enable a further five years of world-leading research.
It is possible that following a Mediterranean diet could have long-term health benefits for patients with breast cancer, according to a paper published recently in Nutrients.
Eating more ultra-processed foods (UPFs) may be associated with a higher risk of developing cancers of upper aerodigestive tract (including the mouth, throat and oesophagus), according to a new study led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC).
The University of Bristol has joined the Evotec beLAB1407 BRIDGE Partnership, an innovative venture aiming to advance new therapeutic drug discoveries.
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Oxford and Bristol, are presented today at the European Association of Urology (EAU) Congress in Milan and published in the New England Journal of Medicine.
